CLINICAL_TRIALS
withdrawal
· 2015-06-30
Clinical Trial Update: IV Iron Treatment of Restless Legs Syndrome [Phase 2]
Summary
A Phase 2 clinical trial evaluating intravenous iron for restless legs syndrome was withdrawn; no results are reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmacosmos A/S | Conditions: Restless Legs Syndrome | Phase 2 | Status: WITHDRAWN